Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Frontiers in Cell and Developmental Biology|November 4, 2014
Common themes in PrP signaling: the Src remains the sameKatharina Ochs, Edward Málaga-TrilloPrion|September 22, 2016
Uncontrolled SFK-mediated protein trafficking in prion and Alzheimer's diseaseEdward Málaga-Trillo, Katharina OchsCurrent Opinion in Neurology|October 7, 2017
The promises of immunotherapy in gliomasIris Mildenberger, Lukas Bunse, Katharina Ochs, et al.Interactive Cardiovascular and Thoracic Surgery|February 9, 2010
Inflammatory myofibroblastic tumour of the lung in a five-year-old girlKatharina Ochs, Beatrix Hoksch, Urs Frey, et al.Current Neurology and Neuroscience Reports|March 8, 2014
Microenvironmental clues for glioma immunotherapyMichael Platten, Katharina Ochs, Dieter Lemke, et al.Current Treatment Options in Neurology|March 30, 2018
Vaccine Strategies in GliomasMichael Platten, Lukas Bunse, Dennis Riehl, et al.Frontiers in Immunology|January 29, 2015
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream EffectorsMichael Platten, Nikolaus von Knebel Doeberitz, Iris Oezen, et al.Oral Oncology|May 19, 2012
Therapy options and long-term results of sinonasal malignanciesAndreas Arnold, Panagiotis Ziglinas, Katharina Ochs, et al.Plos One|June 1, 2011
The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cellsChristiane A Opitz, Ulrike M Litzenburger, Uta Opitz, et al.Journal of Neurochemistry|December 29, 2015
Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4Katharina Ochs, Martina Ott, Katharina J Rauschenbach, et al.Pageof 3